DASH vs RCUS · P/E 76, rev $13.72B vs rev $258.0M
DoorDash, Inc. Class A Common Stock (DASH) versus Arcus Biosciences Inc (RCUS) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported RCUS revenue for 2024-12-31 was $258.0M. Net income was -$283.0M. Revenue was up 120.5% from 2023-12-31 to 2024-12-31. RCUS currently screens at market cap $885.2M.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. RCUS currently screens at market cap $885.2M.
Not investment advice. Open the DASH and RCUS stock pages for the full models.
Not investment advice.